202 related articles for article (PubMed ID: 36596380)
21. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
[TBL] [Abstract][Full Text] [Related]
22. A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
Arnst KE; Wang Y; Hwang DJ; Xue Y; Costello T; Hamilton D; Chen Q; Yang J; Park F; Dalton JT; Miller DD; Li W
Cancer Res; 2018 Jan; 78(1):265-277. PubMed ID: 29180476
[TBL] [Abstract][Full Text] [Related]
23. A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.
Liu Z; Huang L; Zhou T; Chang X; Yang Y; Shi Y; Hao M; Li Z; Wu Y; Guan Q; Zhang W; Zuo D
J Biol Chem; 2022 Jul; 298(7):102063. PubMed ID: 35618020
[TBL] [Abstract][Full Text] [Related]
24. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and Biological Evaluation of Stable Colchicine-Binding Site Tubulin Inhibitors 6-Aryl-2-benzoyl-pyridines as Potential Anticancer Agents.
Chen H; Deng S; Albadari N; Yun MK; Zhang S; Li Y; Ma D; Parke DN; Yang L; Seagroves TN; White SW; Miller DD; Li W
J Med Chem; 2021 Aug; 64(16):12049-12074. PubMed ID: 34378386
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
Tian C; Chen X; Zhang Z; Wang X; Liu J
Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843
[TBL] [Abstract][Full Text] [Related]
28. Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin.
Boichuk S; Syuzov K; Bikinieva F; Galembikova A; Zykova S; Gankova K; Igidov S; Igidov N
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566235
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors.
Liang T; Zhou X; Lu L; Dong H; Zhang Y; Xu Y; Qi J; Zhang Y; Wang J
Bioorg Chem; 2021 May; 110():104793. PubMed ID: 33770673
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity.
Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD
PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potent cytotoxic ortho-aryl chalcones as new scaffold targeting tubulin and mitosis with affinity-based fluorescence.
Zhu C; Zuo Y; Wang R; Liang B; Yue X; Wen G; Shang N; Huang L; Chen Y; Du J; Bu X
J Med Chem; 2014 Aug; 57(15):6364-82. PubMed ID: 25061803
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Yan XY; Leng JF; Chen TT; Zhao YJ; Kong LY; Yin Y
Eur J Med Chem; 2022 Jul; 237():114372. PubMed ID: 35447432
[TBL] [Abstract][Full Text] [Related]
35. Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties.
Chen H; Deng S; Wang Y; Albadari N; Kumar G; Ma D; Li W; White SW; Miller DD; Li W
J Med Chem; 2020 Jan; 63(2):827-846. PubMed ID: 31860298
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel N-aryl-2-trifluoromethyl-quinazoline-4-amine derivatives as the inhibitors of tubulin polymerization in leukemia cells.
Wu H; Wang LS; Li P; Yu J; Cheng S; Yu G; Ahmad M; Meng XL; Luo H; Xu BX
Eur J Med Chem; 2023 Aug; 256():115470. PubMed ID: 37201429
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities.
Ren Y; Wang Y; Li G; Zhang Z; Ma L; Cheng B; Chen J
J Med Chem; 2021 Apr; 64(8):4498-4515. PubMed ID: 33788562
[TBL] [Abstract][Full Text] [Related]
39. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
